Zusammenfassung
Die Störung der Nahrungspassage beeinträchtigt die Lebensqualität unabhängig von der zugrunde liegenden Erkrankung ganz erheblich. Besondere Aspekte ergeben sich beim inkurablen malignen Leiden durch die begrenzte Lebenserwartung der Patienten und das durch die fortgeschrittene Tumorerkrankung per se erhöhte Operationsrisiko. Die Operationsindikation ergibt sich damit aus Abwägung von individuellem Leidensdruck, möglicher Verbesserung, Risiko des Eingriffes und Lebenserwartung. Gerade wegen der begrenzten Lebenserwartung hat die Wahl eines risikoarmen Verfahrens eine besondere Bedeutung.
Abstract
Impaired intestinal passage considerably reduces quality of life irrespective of the underlying condition. Limited life expectancy and increased operative risk of advanced malignant disease add particular weight to this issue. The indication for operative therapy results from carefully weighing individual incapacity and potential gain vs operative risk and life expectancy. Exactly because life expectancy is quite limited, selection of an effective, low-risk procedure is of utmost importance to benefit the patient.
Literatur
Andersen JR, Sörensen SM, Kruse A, Rokkjaer M, Matzen P (1989) Randomized trial of endoscopic endoprosthesis versus operative bypass in malignant obstructive jaundice. Gut 30: 1132–1135
Angorn IB, Haffejee AA (1983) Pulsion intubation v. retrosternal bypass for palliation of unresectable carcinoma of the upper thoracic oesophagus. Br J Surg 70: 335–338
Baer HU, Stain S, Dennison AR, Maddern GJ, Blumbart LH (1994) The effet of communication between the right and left liver on outcome of surgical drainage for jaundice due to malignant obstruction at hilus of the liver Hepatobiliary Pancreat Surg 8: 27–31
Bergamaschi R, Marvik R, Thoresen JE, Ystgaard B, Johnsen G, Myrvold HE (1998) Open versus laparoscopic gastrojejunostomy for palliation in advanced pancreatic cancer. Surg Laparosc Endosc 8(2): 92–96
Blair SL, Chu DZ, Schwarz RE (2001) Outcome of palliative operations for malignant bowel obstruction in patients with peritoneal carcinomatosis fron nongynaecological cancer. Ann Surg Oncol 8: 632–637
Bornman PC, Harries-JonesEP, Tobias R, van Stiegmann G, Terblanche J (1987) Prospective controlled trial of transhepatic biliary endoprosthesis vs bypass surgery for incurable carcinoma of thze head of the pancreas. Lancet II 69–74
Butler JA, Cameron BL, Morrow M, Kahng K, Tom J (1991) Small bowel obstruction in patients with prior history of malignancy. Am J Surg 162 (6): 624–628
Dormann A, Meisner S, Verin N, Wenk Lang A (2004) Self-expanding metal stents for gastroduodenal malignancies: systematic review of their clinical effectiveness. Endoscopy 6: 543–550
Espat NJ, Brennan MF, Conlon KC (1999) Patients with laparoscopically staged unresectable pancreatic adenocarcinoma do not require subsequent surgical biliary or gastric bypass. J Am Coll Surg 188(6): 649–655
Fiori E, Lamazza A, Volpino P et al. (2004) Palliative management of malignant antro-pyloric strictures. Gastroenterostomy vs. endoscopic stenting. A randomized prospective trial. Anticancer Res 24: 269–271
House MG, Choti MA (2005) Palliative therapy for pancreatic/biliary cancer. Surg Clin N Am 85: 359–371
Jarnagin WR (2000) Cholangiocarcinoma of the extrahepatic bile ducts. Semin Surg Oncol 19: 156–176
Junginger T, Ketterer K (1999) Palliativtherapie bei gastrointestinaler Obstruktion. Chirurg 70: 1397–1401
Khot U, Wenk B, Lang A, Murali K, Parker MC (2002) Systematic review of the clinical evidence on colorectal self expanding metal stents. Br J Surg 89: 1096–1102
Kirschner MB (1920) Ein neues Verfahren der Oesophagoplastik. Langenbeck’S Arch Chir 114: 606–610
Klempa I, Arnold W (1994) Palliative chirurgische und endoskopische Therapie maligner Gallenwegsverschlüsse. Chirurg 65: 836–848
Lai ECS, Chu KM, Lo CY et al. (1992) Choice of palliation for malignant hilar obstruction. Am J Surg 163: 208–211
Lillemoe KD, Cameron JL, Hardacre JM et al. (1999) Is prophylactic gastrojejunostomy indicated for unresectable periampullary cancer? A prospective randomized trial. Ann Surg 230: 322–328
Liu SK, Church JM, Lavery IC, Fazio VW (1997) Operation in patients with incurrable colon cancer – is it worthwhile? Dis Colon Rectum 40: 11–14
Mannell A, Becker PJ, Nissenbaum M (1988) Bypass surgery for unresectable oesophageal cancer: early and late results. Br J Surg 75: 283–286
Meunier B, Stasik C, Raoul JL, Spiliopoulos Y, Lakehal M, Campion JP, Launois B (1998) Gastric bypass for malignant esophagotracheal fistula. A series of 21 cases. Eur J Cardiothor Surg 13: 184–189
Miller G, Boman J, Shrier I, Gordon PH (2000) Small bowel obstruction secondary to malignant disease: an 11 year audit. Can J Surg 43: 353–358
Neuberger TJ, Wade TP, Swope TJ, Virgo KS, Johnson FE (1993) Palliative operations for pancreatic cancer in the hospitals of the U.S. Department of Veterans Affairs from 1987 to 1991. Am J Surg 166: 632–636
Ortner MEJ, Caca K, Berr F et al. (2003) Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study. Gastroenterology 125: 1355–1363
Osman HS, Rashid HI, Sathananthan N, Parker MC (2000) The cost effectivness of self expanding metal stents in the management of malignant left sided large bowel obstruction. Colorectal Dis 2: 233–237
O‘Suilleabhain CB, Madhavan KK (2004) A modification of segment III intrahepatic cholangiojejunostomy. Am J Surg 187: 131–133
Sharma D, De Silva J, Saxena A, Agrawal S, Raina VK (2000) In continuity fundic bypass for palliation in unresectable carcinoma of the oesophagus: a previously unreported procedure. Dig Surg 17: 303–306
Sheperd HA, Royle G, Ross APR et al. (1988) Endoscopic biliary endoprosthesis in the palliation of malignant obstruction of the distal common bile duct. A randomized trial. Br J Surg 75: 1166–1168
Shyr YM, Su CH, Wu CW, Lui WY (2000) Prospective study of gastric outlet obstruction in unresectable periampullary adenocarcinoma. World J Surg 24: 60–64
Shyr YM, Su CH, King KL, Wang HC, Lo SS, Wu CW, v Lui WY (1997) Randomized trial of three types of gastrojejunostomy in unresectable periampullary cancer. Surgery 121: 506–512
Suzuki S, Kurachi K, Yokoi Y et al. (2001) Intrahepatic cholangiojejunostomy for unresectable malignant biliary tumors with obstructive jaundice. J Hepatobiliary Pancreat Surg 8: 124–129
Tachibana M, Dhar DK, Kinugasa S et al. (2002) Surgical treatment for locally advanced T4 squamous cell carcinoma of the thoracic esophagus. Dysphagia 17: 255–261
Tang E, Davis J, Silberman H (1995) Bowel obstruction in cancer patients. Arch Surg 130 (8)
Telford JJ, Carr-Locke DL, Baron TH, Tringali A, Parsons WG, Gabbrielli A, Costamagna G (2004) Palliation of patients with malignant gastric outlet obstruction with the enteral Wallstent: outcomes from a multicenter study. Gastrointest Endosc 60: 916–920
Thiele H, Trede M (1987) Die „Cross-Section“-Gastroenterostomie. Chirurg 58: 274–276
Urbach DR, Bell CM, Swanstrom LL, Hansen PD (2003) Cohort study of surgical bypyss to he gallbladder or bile duct for the palliation of jaundice due to pancreatic cancer. Ann Surg 237: 89–93
Van Heek NT, DeCastro SM, vanEijck CH et al. (2003) Ann Surg 238: 894–902
Whooley BP, Law S, Murthy SC, Alexandrou A, Chu KM, Wong J (2002) The Kirschner Operation in unresectable esophageal cancer. Current application. Arch Surg 137: 1228–1232
Yilmaz S, Kirimlioglu V, Katz DA, Kayaalp C, Caglikulekci M, Ara C (2001) Randomised clinical trial of two bypass operations for unresectable cancer of the pancreatic head. Eur J Surg 167: 770–776
Zaima M, Mitsoyoshi A, Komori J, Shinkura N (2005) Segment VI cholangiochole-cystostomy for unresectable malignant obstruction at the hepatic hilum. Hepato-Gastroenterology 52: 1362–1363
Interessenkonflikt
Es besteht kein Interessenkonflikt. Der korrespondierende Autor versichert, dass keine Verbindungen mit einer Firma, deren Produkt in dem Artikel genannt ist, oder einer Firma, die ein Konkurrenzprodukt vertreibt, bestehen. Die Präsentation des Themas ist unabhängig und die Darstellung der Inhalte produktneutral.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wojtyczka, A., Moesta, T., Kuntz, C. et al. Bypasschirurgie zur Palliation. Chirurg 77, 210–218 (2006). https://doi.org/10.1007/s00104-006-1165-8
Issue Date:
DOI: https://doi.org/10.1007/s00104-006-1165-8